Krebs Cycle Metabolite Profiling for Identification and Stratification of Pheochromocytomas/Paragangliomas due to Succinate Dehydrogenase Deficiency
Open accessAbstract
Context: Mutations of succinate dehydrogenase A/B/C/D genes (SDHx) increase susceptibility to development of pheochromocytomas and paragangliomas (PPGLs), with particularly high rates of malignancy associated with SDHB mutations. Objective: We assessed whether altered succinate dehydrogenase product-precursor relationships, manifested by differences in tumor ratios of succinate to fumarate or other metabolites, might aid in identifying and stratifying patients with SDHx mutations. Design, Setting, and Patients: PPGL tumor specimens from 233 patients, including 45 with SDHx mutations, were provided from eight tertiary referral centers for mass spectrometric analyses of Krebs cycle metabolites. Main Outcome Measure: Diagnostic performance of the succinate:fumarate ratio for identification of pathogenic SDHx mutations. Results: SDH-deficient PPGLs were characterized by 25-fold higher succinate and 80% lower fumarate, cis-aconitate, and isocitrate tissue levels than PPGLs without SDHx mutations. Receiver-operating characteristic curves for use of ratios of succinate to fumarate or to cis-aconitate and isocitrate to identify SDHx mutations indicated areas under curves of 0.94 to 0.96; an optimal cut-off of 97.7 for the succinate:fumarate ratio provided a diagnostic sensitivity of 93% at a specificity of 97% to identify SDHX-mutated PPGLs. Succinate:fumarate ratios were higher in both SDHB-mutated and metastatic tumors than in those due to SDHD/C mutations or without metastases. Conclusions: Mass spectrometric-based measurements of ratios of succinate:fumarate and other metabolites in PPGLs offer a useful method to identify patients for testing of SDHx mutations, with additional utility to quantitatively assess functionality of mutations and metabolic factors responsible for malignant risk.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
SDH mutation was discovered in paraganglioma and pheochromocytoma, and later in gastrointestinal, neuroblastoma, renal, thyroid, and testicular tumors.
“In 2008, mutation of SDH was discovered in cancers such as paraganglioma and pheochromocytoma cells124. Later, similar observations were made in gastrointestinal tumors, neuroblastomas, renal tumors, thyroid tumors, and testicular tumors125,126.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [124]
Cites
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176 · see citing works
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · see citing works
Pollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi227 · Cited by 865 · see citing works
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas
Choi, C., Ganji, S. K., DeBerardinis, R. J., Hatanpaa, K. J., Rakheja, D., Kovacs, Z., Yang, X.-L., Mashimo, T., Raisanen, J. M., Marin-Valencia, I., et al. (2012) · Nature Medicine · doi:10.1038/nm.2682 · Cited by 839 · see citing works
SDH mutations establish a hypermethylator phenotype in paraganglioma
Letouzé, E., Martinelli, C., Loriot, C., Burnichon, N., Abermil, N., Ottolenghi, C., Janin, M., Menara, M., Nguyen, A. T., Benit, P., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.018 · Cited by 776 · see citing works
Janeway, K. A., Kim, S. Y., Lodish, M., Nosé, V., Rustin, P., Gaal, J., Dahia, P. L. M., Liegl, B., Ball, E. R., Raygada, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009199108 · Cited by 628 · see citing works
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaı̂tre, X. (2003) · PubMed · Cited by 541 · see citing works
Eisenhofer, G., Lenders, J. W. M., Siegert, G., Bornstein, S. R., Friberg, P., Milosevic, D., Mannelli, M., Linehan, W. M., Adams, K. T., Timmers, H. J. L. M., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.07.016 · Cited by 375 · see citing works
Self-citationGermline SDHB Mutations and Familial Renal Cell Carcinoma
Ricketts, C. J., Woodward, E. R., Killick, P., Morris, M. R., Astuti, D., Latif, F., & Maher, E. R. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn254 · Cited by 341 · see citing works
An Update on the Genetics of Paraganglioma, Pheochromocytoma, and Associated Hereditary Syndromes
Gimenez‐Roqueplo, A., Dahia, P. L. M., & Robledo, M. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1301302 · Cited by 289 · see citing works
Self-citationThe Mitochondrial Chaperone TRAP1 Promotes Neoplastic Growth by Inhibiting Succinate Dehydrogenase
Sciacovelli, M., Guzzo, G., Morello, V., Frezza, C., Zheng, L., Nannini, N., Calabrese, F., Laudiero, G., Esposito, F., Landriscina, M., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.019 · Cited by 269 · see citing works
The Warburg effect is genetically determined in inherited pheochromocytomas
Favier, J., Brière, J.-J., Burnichon, N., Rivière, J., Vescovo, L., Benit, P., Giscos-Douriez, I., De Reyniès, A., Bertherat, J., Badoual, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007094 · Cited by 232 · see citing works
Dinardo, C. D., PROPERT, K. J., Loren, A. W., Paietta, E. M., Sun, Z., Levine, R. L., Straley, K. S., Yen, K. E., Patel, J. P., Agresta, S. V., et al. (2013) · Blood · doi:10.1182/blood-2013-03-493197 · Cited by 197 · see citing works
Ward, P. S., Cross, J. R., Lü, C., Weigert, O., Abdel-Wahab, O. I., Levine, R. L., Weinstock, D. M., Sharp, K. A., & Thompson, C. B. (2011) · Oncogene · doi:10.1038/onc.2011.416 · Cited by 191 · see citing works
Succinate inhibition of α-ketoglutarate-dependent enzymes in a yeast model of paraganglioma
Smith, E. H., Janknecht, R., & Maher, L. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm275 · Cited by 169 · see citing works
Peitzsch, M., Prejbisz, A., Kroiß, M., Beuschlein, F., Arlt, W., Januszewicz, A., Siegert, G., & Eisenhofer, G. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2012.012112 · Cited by 120 · see citing works
Self-citationEisenhofer, G., Tischler, A. S., & de Krijger, R. R. (2011) · Endocrine Pathology · doi:10.1007/s12022-011-9188-1 · Cited by 111 · see citing works
Self-citationO′Flaherty, L., Adam, J., Heather, L. C., Zhdanov, A. V., Chung, Y., Miranda, M. X., Croft, J., Olpin, S. E., Clarke, K. J., Pugh, C. W., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq305 · Cited by 108 · see citing works
Jafri, M., & Maher, E. R. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0497 · Cited by 106 · see citing works
Rattenberry, E., Vialard, L., Yeung, A. C. Y., Bair, H., McKay, K., Jafri, M., Canham, N. L. E., Cole, T. R. P., Dénes, J., Hodgson, S. V., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1319 · Cited by 102 · see citing works
Peitzsch, M., Pelzel, D., Glöckner, S., Prejbisz, A., Faßnacht, M., Beuschlein, F., Januszewicz, A., Siegert, G., & Eisenhofer, G. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.12.031 · Cited by 99 · see citing works
Self-citationMcWhinney, S. R., Pilarski, R. T., Forrester, S. R., Schneider, M. C., Sarquis, M. M., Dias, E. P., & Eng, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0769 · Cited by 89 · see citing works
The management of head-and-neck paragangliomas
Capatina, C. A.-M., Ntali, G., Karavitaki, N., & Grossman, A. B. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0223 · Cited by 79 · see citing works
Lendvai, N. K., Pawlosky, R. J., Bullova, P., Eisenhofer, G., Patócs, A., Veech, R. L., & Pacák, K. (2013) · Endocrinology · doi:10.1210/en.2013-1549 · Cited by 76 · see citing works
Self-citationKelly, A. D., Breitkopf, S. B., Yuan, M., Goldsmith, J. D., Spentzos, D., & Asara, J. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025357 · Cited by 76 · see citing works
Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: A possible hot spot?
Cascón, A., Montero‐Conde, C., Ruiz‐Llorente, S., Mercadillo, F., Letón, R., Rodríguez‐Antona, C., Martínez–Delgado, B., Delgado, M., Díez, A., Rovira, A., et al. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20283 · Cited by 73 · see citing works
Self-citationPuzzling Patterns of Predisposition
Pollard, P. J., & Ratcliffe, P. J. (2009) · Science · doi:10.1126/science.1173362 · Cited by 62 · see citing works
Rao, J. U., Engelke, U. F. H., Rodenburg, R. J., Wevers, R. A., Pacák, K., Eisenhofer, G., Qin, N., Küsters, B., Goudswaard, A. G., Lenders, J. W. M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3922 · Cited by 58 · see citing works
Self-citationNext-Generation Sequencing for Clinical Diagnostics
Jacob, H. J. (2013) · New England Journal of Medicine · doi:10.1056/nejme1310846 · Cited by 57 · see citing works
Merlo, A., Fernández, S. B. D. Q., Secades, P., Zambrano, I., Balbı́n, M., Astudillo, A., Scola, B., Arístegui, M., Suarez, C. M., & Chiara, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2410 · Cited by 51 · see citing works
A New Specific Succinate-Glutamate Metabolomic Hallmark in Sdhx-Related Paragangliomas
Impériale, A., Moussallieh, F., Sebag, F. A., Brunaud, L., Barlier, A., Elbayed, K., Bachellier, P., Goichot, B., Pacák, K., Namer, I. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080539 · Cited by 43 · see citing works
Juratli, T. A., Peitzsch, M., Geiger, K. D., Schackert, G., Eisenhofer, G., & Krex, D. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not006 · Cited by 40 · see citing works
Self-citationRapizzi, E., Ercolino, T., Canu, L., Giaché, V., Francalanci, M., Pratesi, C., Valeri, A., & Mannelli, M. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0263 · Cited by 28 · see citing works
Self-citationPitfalls in Genetic Analysis of Pheochromocytomas/Paragangliomas—Case Report
Canu, L., Rapizzi, E., Zampetti, B., Fucci, R., Nesi, G., Richter, S., Qin, N., Giaché, V., Bergamini, C., Parenti, G., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4453 · Cited by 9 · see citing works
Self-citationWhere metabolism meets oncogenesis: another false lead?
Grossman, A. B. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70003-6 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Glutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021 · see citing works
Papathomas, T. G., Oudijk, L., Persu, A., Gill, A. J., van Nederveen, F. H., Tischler, A. S., Tissier, F., Volante, M., Matías‐Guiu, X., Smid, M., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.41 · Cited by 228 · see citing works
Self-citationCurrent Approaches and Recent Developments in the Management of Head and Neck Paragangliomas
Taïeb, D., Kaliski, A., Boedeker, C. C., Martucci, V. L., Fojo, T., Adler, J. R., & Pacák, K. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1026 · Cited by 169 · see citing works
New treatment strategies for advanced-stage gastrointestinal stromal tumours
Klug, L. R., Khosroyani, H. M., Kent, J. D., & Heinrich, M. C. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00606-4 · Cited by 143 · see citing works
SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery
Saxena, N., Maio, N., Crooks, D. R., Ricketts, C. J., Yang, Y., Wei, M.-H., Fan, T. W. ‐., Lane, A. N., Sourbier, C., Singh, A., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv287 · Cited by 121 · see citing works
Biochemical Assessment of Pheochromocytoma and Paraganglioma
Eisenhofer, G., Pamporaki, C., & Lenders, J. W. M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad011 · Cited by 118 · see citing works
Self-citationRichter, S., Gieldon, L., Pang, Y. K., Peitzsch, M., Huynh, T., Letón, R., Viana, B., Ercolino, T., Mangelis, A., Rapizzi, E., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0106-5 · Cited by 99 · see citing works
Self-citationKadhi, O. A., Melchini, A., Mithen, R. F., & Saha, S. (2017) · Journal of Analytical Methods in Chemistry · doi:10.1155/2017/5391832 · Cited by 94 · see citing works
Oncometabolites: A New Paradigm for Oncology, Metabolism, and the Clinical Laboratory
Collins, R. R. J., Patel, K., Putnam, W. C., Kapur, P., & Rakheja, D. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.267666 · Cited by 90 · see citing works
SDHi fungicides: An example of mitotoxic pesticides targeting the succinate dehydrogenase complex
Tête, A., Debizet, K., Imler, J., Tomkiewicz, C., Blanc, É., Barouki, R., Coumoul, X., & Bortoli, S. (2023) · Environment International · doi:10.1016/j.envint.2023.108219 · Cited by 91 · see citing works
Remacha, L., Comino‐Méndez, I., Richter, S., Contreras, L., Currás-Freixes, M., Pita, G., Letón, R., Galarreta, A., Torres‐Pérez, R., Honrado, E., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2250 · Cited by 88 · see citing works
Self-citationEisenhofer, G., Klink, B., Richter, S., Lenders, J. W. M., & Robledo, M. (2017) · Europe PMC (PubMed Central) · Cited by 84 · see citing works
Self-citationGudgeon, N. H., Munford, H., Bishop, E. L., Hill, J., Fulton-Ward, T., Bending, D., Roberts, J., Tennant, D. A., & Dimeloe, S. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111193 · Cited by 78 · see citing works
Clinical implications of the oncometabolite succinate in SDHx ‐mutation carriers
Eijkelenkamp, K., Osinga, T. E., Links, T. P., & van der Horst‐Schrivers, A. N. A. (2019) · Clinical Genetics · doi:10.1111/cge.13553 · Cited by 77 · see citing works
Döncző, B., & Guttman, A. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.03.065 · Cited by 74 · see citing works
Loss of SDHB Promotes Dysregulated Iron Homeostasis, Oxidative Stress, and Sensitivity to Ascorbate
Goncalves, J., Moog, S., Morin, A., Gentric, G., Müller, S., Morrell, A. P., Kľučková, K., Stewart, T. J., Andoniadou, C. L., Lussey‐Lepoutre, C., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2936 · Cited by 72 · see citing works
Lussey‐Lepoutre, C., Bellucci, A., Morin, A., Buffet, A., Amar, L., Janin, M., Ottolenghi, C., Zinzindohoué, F., Autret, G., Burnichon, N., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1576 · Cited by 70 · see citing works
Impériale, A., Moussallieh, F., Roche, P., Battini, S., Çiçek, A. E., Sebag, F. A., Brunaud, L., Barlier, A., Elbayed, K., Loundou, A., et al. (2015) · Neoplasia · doi:10.1016/j.neo.2014.10.010 · Cited by 69 · see citing works
Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry
Juhlin, C. C. (2021) · Endocrine Pathology · doi:10.1007/s12022-021-09675-0 · Cited by 67 · see citing works
GEP- NETS UPDATE: Genetics of neuroendocrine tumors
Crona, J., & Skogseid, B. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0972 · Cited by 66 · see citing works
Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma
Kľučková, K., & Tennant, D. A. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2801-6 · Cited by 66 · see citing works
Pheochromocytoma: The First Metabolic Endocrine Cancer
Jochmanová, I., & Pacák, K. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0606 · Cited by 65 · see citing works
Antonio, K. L., Valdez, M. M. N., MERCADO-ASIS, L. B., Taïeb, D., & Pacák, K. (2020) · Gland Surgery · doi:10.21037/gs.2019.10.25 · Cited by 65 · see citing works
MacFarlane, J., Seong, K. C., Bisambar, C., Madhu, B., Allinson, K. S. J., Marker, A. J., Warren, A. Y., Park, S., Giger, O., Challis, B., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14289 · Cited by 64 · see citing works
Berends, A. M. A., Eisenhofer, G., Fishbein, L. M., van der Horst‐Schrivers, A. N. A., Kema, I. P., Links, T. P., Lenders, J. W. M., & Kerstens, M. N. (2019) · Cancers · doi:10.3390/cancers11081121 · Cited by 63 · see citing works
Self-citationPheochromocytoma: A Genetic And Diagnostic Update
MERCADO-ASIS, L. B., Wolf, K. I., Jochmanová, I., & Taïeb, D. (2017) · Endocrine Practice · doi:10.4158/ep-2017-0057 · Cited by 58 · see citing works
Precision medicine in pheochromocytoma and paraganglioma: current and future concepts
Björklund, P., Pacák, K., & Crona, J. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12507 · Cited by 57 · see citing works
Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas
Richter, S., Klink, B., Nacke, B., de Cubas, A. A., Mangelis, A., Rapizzi, E., Meinhardt, M., Skondra, C. D., Mannelli, M., Robledo, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3856 · Cited by 53 · see citing works
Self-citationDahia, P. L. M., Clifton-Bligh, R. J., Gimenez‐Roqueplo, A., Robledo, M., & Jiménez, C. (2020) · Endocrine Related Cancer · doi:10.1530/erc-19-0435 · Cited by 52 · see citing works
Self-citationBénit, P., Goncalves, J., El‐Khoury, R., Rak, M., Favier, J., Gimenez‐Roqueplo, A., & Rustin, P. (2022) · Biomedicines · doi:10.3390/biomedicines10081788 · Cited by 49 · see citing works
New Biology of Pheochromocytoma and Paraganglioma
Pacák, K. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.09.003 · Cited by 44 · see citing works
Impact of LC-MS/MS on the laboratory diagnosis of catecholamine-producing tumors
Eisenhofer, G., Peitzsch, M., & McWhinney, B. C. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2016.01.027 · Cited by 43 · see citing works
Self-citationThe 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors
Xekouki, P., Brennand, A., Whitelaw, B., Pacák, K., & Stratakis, C. A. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0661-0341 · Cited by 43 · see citing works
Wallace, P. W., Conrad, C., Brückmann, S., Pang, Y. K., Caleiras, E. J., Murakami, M., Korpershoek, E., Zhuang, Z., Rapizzi, E., Kroiß, M., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5472 · Cited by 43 · see citing works
Self-citationThe VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
Song, P., Zhang, J., Tan, X., Huang, Y., Xu, J., Silk, N., Zhang, D., Liu, Q., & Jiang, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.586857 · Cited by 42 · see citing works
Armstrong, N., Storey, C. M., Noll, S. E., Margulis, K., Soe, M. H., Xu, H., Yeh, B. T., Fishbein, L. M., Kebebew, E., Howitt, B. E., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110453 · Cited by 41 · see citing works
Wojakowska, A., Marczak, Ł., Jelonek, K., Polański, K., Widłak, P., & Pietrowska, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136902 · Cited by 40 · see citing works
Matlac, D. M., Vanova, K. H., Bechmann, N., Richter, S., Inderhees, J., Ghayee, H. K., Ge, G., Abunimer, L., WESLEY, R. A., Aherrahrou, R., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.589451 · Cited by 40 · see citing works
Self-citationMagnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics
Varoquaux, A. D., Fur, Y. L., Impériale, A., Reyre, A., Montava, M., Fakhry, N., Namer, I. J., Moulin, G., Pacák, K., Guye, M., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0246 · Cited by 39 · see citing works
Gieldon, L., William, D., Hackmann, K., Jahn, W., Jahn, A., Wagner, J., Rump, A., Bechmann, N., Nölting, S., Knösel, T., et al. (2019) · Cancers · doi:10.3390/cancers11060809 · Cited by 39 · see citing works
Self-citationEpigenetic and metabolic reprogramming of SDH-deficient paragangliomas
Moog, S., Lussey‐Lepoutre, C., & Favier, J. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0346 · Cited by 39 · see citing works
Casey, R. T., McLean, M. A., Madhu, B., Challis, B., ten Hoopen, R., Roberts, T. A., Clark, G. R., Pitfield, D., Simpson, H., Bulusu, V. R., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00191 · Cited by 38 · see citing works
Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas
Mete, Ö., Pakbaz, S., Lerário, A. M., Giordano, T. J., & Asa, S. L. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001715 · Cited by 38 · see citing works
Utility of the succinate:fumarate ratio for assessing SDH dysfunction in different tumor types
Kim, E., Wright, M. J., Sioson, L., Novos, T., Gill, A. J., Benn, D. E., White, C., Dwight, T., & Clifton-Bligh, R. J. (2016) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2016.12.006 · Cited by 38 · see citing works
Structural and functional consequences of succinate dehydrogenase subunit B mutations
Kim, E., Rath, E. M., Tsang, V., Duff, A. P., Robinson, B. G., Church, W. B., Benn, D. E., Dwight, T., & Clifton-Bligh, R. J. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0099 · Cited by 37 · see citing works
Circulating Metabolites and Survival Among Patients With Pancreatic Cancer
Yuan, C., Clish, C. B., Wu, C. H., Mayers, J. R., Kraft, P. L., Townsend, M. K., Zhang, M., Tworoger, S. S., Bao, Y., Qian, Z. R., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv409 · Cited by 37 · see citing works
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids
D’Antongiovanni, V., Martinelli, S., Richter, S., Canu, L., Guasti, D., Mello, T., Romagnoli, P., Pacák, K., Eisenhofer, G., Mannelli, M., et al. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0212 · Cited by 36 · see citing works
Self-citationMutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin
Biedermann, J., Preussler, M., Conde, M., Peitzsch, M., Richter, S., Wiedemuth, R., Abou‐El‐Ardat, K., Krüger, A., Meinhardt, M., Schackert, G., et al. (2019) · Cancers · doi:10.3390/cancers11122028 · Cited by 36 · see citing works
Self-citationLussey‐Lepoutre, C., Bellucci, A., Burnichon, N., Amar, L., Buffet, A., Drossart, T., Fontaine, S., Clémеnt, O., Bénit, P., Rustin, P., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04633-9 · Cited by 34 · see citing works
The Evolving Role of Succinate in Tumor Metabolism: An 18F-FDG–Based Study
Garrigue, P., Bodin-Hullin, A., Balasse, L., Fernandez-Sauze, S., Essamet, W., Dignat‐George, F., Pacák, K., Guillet, B. A., & Taïeb, D. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.192674 · Cited by 33 · see citing works
Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series
Else, T., Lerário, A. M., Everett, J. N., Haymon, L., Wham, D., Mullane, M. P., Wilson, T. L. S., Rainville, I. R., Rana, H. Q., Worth, A. J., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0358 · Cited by 33 · see citing works
Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis
Qin, N., Paisana, E., Langini, M., Picard, D. J., Malzkorn, B., Custódia, C., Cascão, R., Meyer, F.-D., Blümel, L., Göbbels, S., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac068 · Cited by 33 · see citing works
Self-citationOxygen Concentration Controls Epigenetic Effects in Models of Familial Paraganglioma
Her, Y. F., Nelson-Holte, M. H., & Maher, L. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127471 · Cited by 32 · see citing works
Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
Cascón, A., Remacha, L., Calsina, B., & Robledo, M. (2019) · Cancers · doi:10.3390/cancers11050683 · Cited by 32 · see citing works
Self-citationSater, Z. A., Jha, A., Hamimi, A., Mandl, A., Hartley, I. R., Gubbi, S., Patel, M. A., Gonzales, M., Taïeb, D., Civelek, A. C., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz314 · Cited by 31 · see citing works
Richter, S., D’Antongiovanni, V., Martinelli, S., Bechmann, N., Riverso, M., Poitz, D. M., Pacák, K., Eisenhofer, G., Mannelli, M., & Rapizzi, E. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2907-x · Cited by 30 · see citing works
Self-citationThe Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives
Uher, O., Vanova, K. H., Taïeb, D., Calsina, B., Robledo, M., Clifton-Bligh, R. J., & Pacák, K. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae005 · Cited by 29 · see citing works
Self-citationPheochromocytoma: Gasping for Air
Jochmanová, I., Zhuang, Z., & Pacák, K. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0231-4 · Cited by 29 · see citing works
Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours
Loughrey, P. B., Roncaroli, F., Healy, E. G., Weir, P., Madhu, B., Casey, R. T., Hunter, S. J., & Korbonits, M. (2022) · Endocrine Related Cancer · doi:10.1530/erc-22-0157 · Cited by 28 · see citing works
Liu, Z., Ma, J., Jiménez, C., & Zhang, M. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001768 · Cited by 28 · see citing works
Yu, S., Zhou, W., Yu, J., Li, M., Zhang, S., Jiang, X., Wang, H., Ma, X., Zou, Y., Wang, D., et al. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-03984-x · Cited by 28 · see citing works
Tumour microenvironment in pheochromocytoma and paraganglioma
Martinelli, S., Amore, F., Canu, L., Maggi, M., & Rapizzi, E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1137456 · Cited by 26 · see citing works
Self-citationRole of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function
Rapizzi, E., Fucci, R., Giannoni, E., Canu, L., Richter, S., Cirri, P., & Mannelli, M. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0479 · Cited by 26 · see citing works
Self-citationFéral, C. C., Tissot, F. S., Tosello, L., Fakhry, N., Sebag, F. A., Pacák, K., & Taïeb, D. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3586-z · Cited by 26 · see citing works
Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas
Lamy, C., Tissot, H., Faron, M., Baudin, É., Lamartina, L., Pradon, C., Ghuzlan, A. A., Leboulleux, S., Perfettini, J., Paci, A., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac474 · Cited by 25 · see citing works
Casey, R. T., ten Hoopen, R., Ochoa, E., Challis, B., Whitworth, J., Smith, P., Martín, J., Clark, G. R., Rodger, F., Maranian, M. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46124-9 · Cited by 24 · see citing works
Fliedner, S. M. J., Brabant, G. E., & Lehnert, H. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2760-3 · Cited by 22 · see citing works
Adrenal Hormone Interactions and Metabolism: A Single Sample Multi-Omics Approach
Bechmann, N., Watts, D., Steenblock, C., Wallace, P. W., Schürmann, A., Bornstein, S. R., Wielockx, B., Eisenhofer, G., & Peitzsch, M. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1440-0278 · Cited by 21 · see citing works
Self-citationRodent models of pheochromocytoma, parallels in rodent and human tumorigenesis
Lussey‐Lepoutre, C., Buffet, A., Morin, A., Goncalves, J., & Favier, J. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2797-y · Cited by 20 · see citing works
Targeting pheochromocytoma/paraganglioma with polyamine inhibitors
Rai, S. K., Bril, F., Hatch, H. M., Xu, Y., Shelton, L. M., Kalavalapalli, S., Click, A., Lee, D., Beecher, C., Kirby, A., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154297 · Cited by 20 · see citing works
Self-citationLoss of sdhb in zebrafish larvae recapitulates human paraganglioma characteristics
Dona, M., Waaijers, S., Richter, S., Eisenhofer, G., Korving, J., Kamel, S. M., Bakkers, J., Rapizzi, E., Rodenburg, R. J., Zethof, J., et al. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0308 · Cited by 20 · see citing works
Self-citationWang, Y., Liu, B., Li, F., Zhang, Y., Gao, X., Wang, Y., & Zhou, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1274239 · Cited by 18 · see citing works
Fliedner, S. M. J., Shankavaram, U. T., Marzouca, G., ELKAHLOUN, A. G., Jochmanová, I., Därr, R., Linehan, W. M., Timmers, H. J. L. M., Tischler, A. S., Papaspyrou, K., et al. (2016) · Neoplasia · doi:10.1016/j.neo.2016.07.008 · Cited by 18 · see citing works
Self-citationMartinelli, S., Riverso, M., Mello, T., Amore, F., Parri, M., Simeone, I., Mannelli, M., Maggi, M., & Rapizzi, E. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111594 · Cited by 17 · see citing works
Self-citationClinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma
Cascón, A., & Robledo, M. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189141 · Cited by 16 · see citing works
Self-citationMetabolomics in paraganglioma: applications and perspectives from genetics to therapy
Richter, S., Garrett, T. J., Bechmann, N., Clifton-Bligh, R. J., & Ghayee, H. K. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0376 · Cited by 16 · see citing works
Self-citationSousa, S. M. C. D., Toubia, J., Hardy, T., Feng, J., Wang, P. P.-S., SCHREIBER, A. W., Geoghegan, J. M., Hall, R. K., Rawlings, L. H., Buckland, M. E., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa071 · Cited by 16 · see citing works
Novel methods in adrenal research: a metabolomics approach
Papathomas, T. G., Sun, N., Chortis, V., Taylor, A. E., Arlt, W., Richter, S., Eisenhofer, G., Ruiz-Babot, G., Guasti, L., & Walch, A. K. (2019) · Histochemistry and Cell Biology · doi:10.1007/s00418-019-01772-w · Cited by 14 · see citing works
Self-citationBuszewska‐Forajta, M., Patejko, M., Macioszek, S., Sigorski, D., Iżycka‐Świeszewska, E., & Markuszewski, M. J. (2019) · Chromatographia · doi:10.1007/s10337-019-03769-y · Cited by 14 · see citing works
Pheochromocytoma/paraganglioma preclinical models: which to use and why?
Martinelli, S., Maggi, M., & Rapizzi, E. (2020) · Endocrine Connections · doi:10.1530/ec-20-0472 · Cited by 14 · see citing works
Self-citation15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma
Mannelli, M., Rapizzi, E., Fucci, R., Canu, L., Ercolino, T., Luconi, M., & Young, W. F. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0215 · Cited by 14 · see citing works
Self-citationYamamoto, T., Sato, K., Yamaguchi, M., Mitamura, K., & Taga, A. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.10.072 · Cited by 13 · see citing works
Metabolomics in the Diagnosis of Pheochromocytoma and Paraganglioma
Dwight, T., Kim, E., Novos, T., & Clifton-Bligh, R. J. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0926-3790 · Cited by 13 · see citing works
Lee, S., Needleman, L., Park, J. R., Schugar, R. C., Guo, Q., Ford, J. M., & Annes, J. P. (2025) · Journal of Clinical Investigation · doi:10.1172/jci198165 · Cited by 12 · see citing works
Plasma Metabolome Profiling for the Diagnosis of Catecholamine Producing Tumors
März, J., Kurlbaum, M., Roche-Lancaster, O., Deutschbein, T., Peitzsch, M., Prehn, C. P., Weismann, D., Robledo, M., Adamski, J., Faßnacht, M., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.722656 · Cited by 12 · see citing works
Self-citationQin, N., Paisana, E., Picard, D. J., Leprivier, G., Langini, M., Custódia, C., Cascão, R., Conrad, C., Peitzsch, M., Stefanski, A., et al. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04508-y · Cited by 11 · see citing works
Self-citationMartins, R. G., Gonçalves, L. G., Cunha, N., & Bugalho, M. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01101 · Cited by 11 · see citing works
Toward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer
Lakhani, A., Kang, D. H., Kang, Y. E., & Park, J. O. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1814 · Cited by 11 · see citing works
Marden, J. H., Langford, E. A., Robertson, M. A., & Fescemyer, H. W. (2020) · Evolution · doi:10.1111/evo.14095 · Cited by 11 · see citing works
Gregorio, E. D., Miolo, G., Saorin, A., Steffan, A., & Corona, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115574 · Cited by 11 · see citing works
Hart, M. L., Sokolov, D., Danquah, S., Zheng, E., Doan, A. D., Davidsen, K., MacPherson, D. P., & Sullivan, L. B. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01524-w · Cited by 10 · see citing works
Bancel, L.-P., Masso, V., Dessein, A., Aubert, S., Leteurtre, E., Coppin, L., Odou, M., Cao, C. D., Cardot-Bauters, C., & Pigny, P. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad109 · Cited by 10 · see citing works
Clinical and biochemical footprints of inherited metabolic diseases. VIII. Neoplasias
Serrano, T. J., Blau, N., & Ferreira, C. R. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2022.03.011 · Cited by 9 · see citing works
Asensio, A. F., Álvarez-González, E., Rodríguez, A., Sierra, L. M., & Blanco‐González, E. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.338646 · Cited by 9 · see citing works
Lamy, C., Mansard, C., Blondel, L., Mercier, L., Paci, A., & Broutin, S. (2021) · Journal of Chromatography B · doi:10.1016/j.jchromb.2021.123085 · Cited by 8 · see citing works
Gabiache, G., Zadro, C., Rozenblum, L., Vezzosi, D., Mouly, C., Thoulouzan, M., Guimbaud, R., Otal, P., Dierickx, L., Rousseau, H., et al. (2023) · Cancers · doi:10.3390/cancers15184666 · Cited by 8 · see citing works
Identification of Succinate Dehydrogenase Gene Variant Carriers by Blood Biomarkers
Gebhardt, M., Kunath, C., Fröbel, D., Funk, A. M., Peitzsch, M., Nölting, S., Deutschbein, T., Januszewicz, A., Timmers, H. J. L. M., Robledo, M., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae142 · Cited by 7 · see citing works
Self-citationSvendsen, L. K., Rasmussen, Å. K., Klose, M., Krogh, J., & Feldt‐Rasmussen, U. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf584 · Cited by 6 · see citing works
van den Berg, M. F., Bechmann, N., Kooistra, H. S., van Wolferen, M. E., Timmermans‐Sprang, E. P. M., Peitzsch, M., & Galac, S. (2024) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.17148 · Cited by 6 · see citing works
Self-citationPetrák, J., Tevosian, S. G., Richter, S., & Ghayee, H. K. (2024) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2024.101935 · Cited by 5 · see citing works
Self-citation
- Authors
- Richter, S., Peitzsch, M., Rapizzi, E., Lenders, J. W., Qin, N., de Cubas, A. A., Schiavi, F., Rao, J. U., Beuschlein, F., Quinkler, M., Timmers, H. J., Opocher, G., Mannelli, M., Pacak, K., Robledo, M., & Eisenhofer, G.
- Affiliations
- University Hospital Carl Gustav Carus (DE)
- University of Florence (IT)
- Radboud University Medical Center (NL)
- Hereditary Endocrine Cancer Group (A.A.C., M.R.), CNIO, Madrid, Spain
- Istituto Oncologico Veneto (IT)
- LMU Klinikum (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K.P.), National Institutes of Health, 10 Center Drive, MSC-1109, Bethesda, Maryland 20892-1109
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Richter, Susan
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-10-01
- Volume
- 99
- Issue
- 10
- Pages
- 3903-3911
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4184070
- OpenAlex
- W2116263600
- Cited by
- 135
- References
- 35
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 6 · 2023: 16 · 2022: 17 · 2021: 15 · 2020: 14 · 2019: 11 · 2018: 8 · 2017: 12 · 2016: 10 · 2015: 14 · 2014: 1
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Neurology › Neuroblastoma Research and Treatments
- Keywords
- pheochromocytoma, paraganglioma, succinate dehydrogenase deficiency, SDHx mutations, Krebs cycle metabolites, SDHB mutation, metastasis, mutation detection, isocitrate, cis-aconitate
- MeSH terms
- Adolescent, Adrenal Gland Neoplasms, Adult, Aged, Citric Acid Cycle, Female, Follow-Up Studies, Fumarates, Humans, Male, Metabolic Diseases, Middle Aged, Paraganglioma, Pheochromocytoma, Sensitivity and Specificity, Succinate Dehydrogenase, Germ-Line Mutation, Succinic Acid, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review